Physician

Kumarpal Shrishrimal, MD

According to 2025 Medicare claims, Kumarpal Shrishrimal, MD (NPI: 1023217551) practices nephrology in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is RENALCARE ASSOCIATES, S.C. (NPI: 1649300377; TIN: 370995483) and primary practice location at 61603-3168. Shrishrimal is affiliated with the IRCCO (ACO ID: A2619), OSF Healthcare System (ACO ID: A3289), and SBL accountable care organization (ACO ID: A5147), participating under the MSSP model.

Shrishrimal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 782 traditional Medicare patients, billed 2,701 HCPCS/CPT codes, and received $198,066 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,391 prescription claims across 612 beneficiaries totaling $172,874 in drug costs, led by Jardiance (Empagliflozin). DME data shows 357 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $257,314 to $198,066. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $191,359 and ending at $172,874. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	868	4,419	$257,314
2016	925	5,698	$314,081
2017	959	4,867	$351,024
2018	962	4,726	$350,081
2019	1,018	5,283	$359,332
2020	951	3,909	$335,550
2021	765	2,474	$258,255
2022	817	2,294	$225,079
2023	835	1,966	$167,468
2024	782	2,701	$198,066

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	463	3,411	$191,359
2016	514	3,975	$231,731
2017	504	3,864	$276,913
2018	511	3,423	$149,255
2019	526	3,390	$152,993
2020	541	3,460	$139,178
2021	526	3,432	$208,389
2022	519	3,290	$132,531
2023	529	3,188	$117,306
2024	612	3,391	$172,874

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	328	$30,258
2016	N/R	433	$32,483
2017	N/R	271	$18,150
2018	22	352	$25,105
2019	22	355	$27,908
2020	29	469	$34,148
2021	N/R	268	$13,816
2022	N/R	297	$11,584
2023	N/R	226	$9,721
2024	41	357	$8,751

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	86	87	$130
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	189	548	$91
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	144	301	$60
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	404	614	$57
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	418	633	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	85	3,068	$60,057
Velphoro	Sucroferric Oxyhydroxide	11	450	$30,753
Farxiga	Dapagliflozin Propanediol	24	900	$17,112
Calcitriol	Calcitriol	746	49,883	$11,747
Demeclocycline Hcl	Demeclocycline Hcl	33	231	$4,849

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	75	$4,369
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	15	108	$1,976
J7507	Tacrolimus, immediate release, oral, 1 mg	N	12	81	$1,369
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	14	82	$1,028
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	11	$8

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Kumarpal Shrishrimal, MD?

Tedicare shows public-source Medicare data for Kumarpal Shrishrimal, MD (NPI 1023217551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kumarpal Shrishrimal, MD have ACO affiliation data?

Kumarpal Shrishrimal, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), OSF Healthcare System (MSSP, ACO ID A3289), and SBL accountable care organization (MSSP, ACO ID A5147).

What billing organization is linked to Kumarpal Shrishrimal, MD?

Kumarpal Shrishrimal, MD is linked to RENALCARE ASSOCIATES, S.C. (billing NPI 1649300377) in the available physician profile data.

Does Kumarpal Shrishrimal, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.